LatinX harm reduction capital, medication for opioid use disorder, and nonfatal overdose: A structural equation model analysis among people who use drugs in Massachusetts

被引:2
|
作者
Shrestha, Shikhar [1 ,10 ]
Stopka, Thomas J. [1 ]
Hughto, Jaclyn M. W. [2 ,3 ,4 ]
Case, Patricia [5 ]
Palacios, Wilson R. [6 ]
Reilly, Brittni [7 ]
Green, Traci C. [3 ,8 ,9 ]
机构
[1] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA USA
[2] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA
[3] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
[4] Brown Univ, Ctr Hlth Promot & Hlth Equ, Providence, RI USA
[5] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA USA
[6] Univ Massachusetts, Sch Criminol & Justice Studies, Lowell, MA USA
[7] Massachusetts Dept Publ Hlth, Bur Subst Addict Serv, Boston, MA USA
[8] Brandeis Univ, Heller Sch Social Policy & Management, Opioid Policy Res Collaborat, Waltham, MA USA
[9] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI USA
[10] Tufts Univ, Sch Med, Boston, MA 02155 USA
关键词
Opioids; Overdose; Medication for opioid use disorder; Harm reduction capital; PREVENTION; METHADONE; RECOVERY; RISK;
D O I
10.1016/j.drugalcdep.2024.111293
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: We introduce the concept of harm reduction capital (HRCap) as the combination of knowledge, resources, and skills related to substance use risk reduction, which we hypothesize to predict MOUD use and opioid overdose. In this study, we explored the interrelationships between ethnicity, HRCap, nonfatal overdose, and MOUD use among PWUD. Methods: Between 2017 and 2019, people who currently or in the past used opioids and who lived in Massachusetts completed a one-time survey on substance use history, treatment experiences, and use of harm reduction services. We fit first-order measurement constructs for positive and negative HRCap (facilitators and barriers). We used generalized structural equation models to examine the inter-relationships of the latent constructs with LatinX self-identification, past year overdose, and current use of MOUD. Results: HRCap barriers were positively associated with past-year overdose (b=2.6, p<0.05), and LatinX self-identification was inversely associated with HRCap facilitators (b=-0.49, p<0.05). There was no association between overdose in the past year and the current use of MOUD. LatinX self-identification was positively associated with last year methadone treatment (b=0.89, p<0.05) but negatively associated with last year buprenorphine treatment (b=-0.68, p<0.07). Latinx PWUD reported lower positive HRCap than white non-LatinX PWUD and had differential utilization of MOUD. Conclusion: Our findings indicate that a recent overdose was not associated with the current use of MOUD, highlighting a severe gap in treatment utilization among individuals at the highest risk. The concept of HRCap and its use in the model highlight substance use treatment differences, opportunities for intervention, and empowerment.
引用
收藏
页数:8
相关论文
共 39 条
  • [31] Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis
    Ferraro, Claire F.
    Stewart, Daniel E.
    Grebely, Jason
    Tran, Lucy T.
    Zhou, Shally
    Puca, Carla
    Hajarizadeh, Behzad
    Larney, Sarah
    Santo, Thomas, Jr.
    Higgins, Julian P. T.
    Vickerman, Peter
    Degenhardt, Louisa
    Hickman, Matthew
    French, Clare E.
    ADDICTION, 2021, 116 (07) : 1664 - 1676
  • [32] Patterns of socioeconomic marginalization and non-fatal overdose among people who use drugs: A gender-stratified repeated measures latent class analysis
    Mitra, Sanjana
    Richardson, Lindsey
    Cui, Zishan
    Gilbert, Mark
    Milloy, M. -j.
    Hayashi, Kanna
    Kerr, Thomas
    SOCIAL SCIENCE & MEDICINE, 2025, 366
  • [33] Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074
    Lancaster, Kathryn E.
    Mollan, Katie R.
    Hanscom, Brett S.
    Shook-Sa, Bonnie E.
    Ha, Tran, V
    Dumchev, Kostyantyn
    Djoerban, Zubairi
    Rose, Scott M.
    Latkin, Carl A.
    Metzger, David S.
    Go, Vivian F.
    Dvoriak, Sergii
    Reifeis, Sarah A.
    Piwowar-Manning, Estelle M.
    Richardson, Paul
    Hudgens, Michael G.
    Hamilton, Erica L.
    Eshleman, Susan H.
    Susami, Hepa
    Viet Anh Chu
    Djauzi, Samsuridjal
    Kiriazova, Tetiana
    Nhan, Do Thi
    Burns, David N.
    Miller, William C.
    Hoffman, Irving F.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [34] Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder
    Pericot-Valverde, Irene
    Heo, Moonseong
    Niu, Jiajing
    Rennert, Lior
    Norton, Brianna L.
    Akiyama, Matthew J.
    Arnsten, Julia
    Litwin, Alain H.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 234
  • [35] Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs
    Michael Wilson
    Amanda Brumwell
    M. J. Stowe
    Shaun Shelly
    Andrew Scheibe
    Harm Reduction Journal, 19
  • [36] Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs
    Wilson, Michael
    Brumwell, Amanda
    Stowe, M. J.
    Shelly, Shaun
    Scheibe, Andrew
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [37] Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study
    Biello, Katie
    Salhaney, Peter
    Valente, Pablo K.
    Childs, Ellen
    Olson, Jennifer
    Earlywine, Joel J.
    Marshall, Brandon D. L.
    Bazzi, Angela R.
    DRUG AND ALCOHOL DEPENDENCE, 2020, 214
  • [38] Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study
    Shrestha, Roman
    Altice, Frederick L.
    Sibilio, Brian
    Ssenyonjo, Jude
    Copenhaver, Michael M.
    CONTEMPORARY CLINICAL TRIALS, 2019, 82 : 77 - 84
  • [39] Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients
    Sivakumar, Anishaa
    Madden, Lynn
    DiDomizio, Elizabeth
    Eller, Anthony
    Villanueva, Merceditas
    Altice, Frederick L.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 101